These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 33941048)

  • 21. Feasibility and Outcomes of
    Nuño T; Torres MR; Soto S; Sepulveda R; Aceves B; Rosales CB
    Int J Environ Res Public Health; 2023 Oct; 20(21):. PubMed ID: 37947526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan.
    Wu PY; Chen MY; Sheng WH; Hsieh SM; Chuang YC; Cheng A; Pan SC; Wu UI; Chang HY; Luo YZ; Yang SP; Zhang JY; Sun HY; Hung CC
    J Microbiol Immunol Infect; 2019 Aug; 52(4):549-555. PubMed ID: 31036484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic and sociodemographic variation of cardiovascular disease risk in India: A cross-sectional study of 797,540 adults.
    Geldsetzer P; Manne-Goehler J; Theilmann M; Davies JI; Awasthi A; Danaei G; Gaziano TA; Vollmer S; Jaacks LM; Bärnighausen T; Atun R
    PLoS Med; 2018 Jun; 15(6):e1002581. PubMed ID: 29920517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
    Gaziano TA; Abrahams-Gessel S; Alam S; Alam D; Ali M; Bloomfield G; Carrillo-Larco RM; Dorairaj P; Gutierrez L; Irazola V; Levitt NS; Miranda JJ; Bernabe-Ortiz A; Pandya A; Rubinstein A; Steyn K; Xavier D; Yan LL
    Glob Heart; 2016 Mar; 11(1):37-46.e2. PubMed ID: 27102021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of cardiovascular disease risk factors and the Framingham Risk Score in patients undergoing percutaneous intervention over the last 17 years by gender: time-trend analysis from the Mayo Clinic PCI Registry.
    Lee MS; Flammer AJ; Kim HS; Hong JY; Li J; Lennon RJ; Lerman A
    J Prev Med Public Health; 2014 Jul; 47(4):216-29. PubMed ID: 25139168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.
    Zhou H; Zhang C; Ni J; Han X
    BMC Endocr Disord; 2019 Oct; 19(1):98. PubMed ID: 31601203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease risk factors in the Hispanic/Latino population: lessons from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Daviglus ML; Pirzada A; Talavera GA
    Prog Cardiovasc Dis; 2014; 57(3):230-6. PubMed ID: 25242694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge and risk of cardiovascular disease in rural Alabama women.
    Hamner J; Wilder B
    J Am Acad Nurse Pract; 2008 Jun; 20(6):333-8. PubMed ID: 18588661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vivir Con Un Corazón Saludable: a Community-Based Educational Program Aimed at Increasing Cardiovascular Health Knowledge in High-Risk Hispanic Women.
    Romero DC; Sauris A; Rodriguez F; Delgado D; Reddy A; Foody JM
    J Racial Ethn Health Disparities; 2016 Mar; 3(1):99-107. PubMed ID: 26896109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
    Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
    Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular disease risk factors among Latino farmworkers in Oregon.
    López-Cevallos DF; Escutia G; González-Peña Y; Garside LI
    Ann Epidemiol; 2019 Dec; 40():8-12.e1. PubMed ID: 31708406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
    Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
    Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline 10-Year Cardiovascular Risk Scores Predict Cognitive Function in Older Persons, and Particularly Women, Living With Human Immunodeficiency Virus Infection.
    Chow FC; Lyass A; Mahoney TF; Massaro JM; Triant VA; Wu K; Berzins B; Robertson K; Ellis RJ; Tassiopoulos K; Taiwo B; D'Agostino RB
    Clin Infect Dis; 2020 Dec; 71(12):3079-3085. PubMed ID: 31899478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
    Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet Quality and Cardiovascular Disease Risk in Postmenopausal Women With Type 2 Diabetes Mellitus: The Women's Health Initiative.
    Hirahatake KM; Jiang L; Wong ND; Shikany JM; Eaton CB; Allison MA; Martin L; Garcia L; Zaslavsky O; Odegaard AO
    J Am Heart Assoc; 2019 Oct; 8(19):e013249. PubMed ID: 31533514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.